Poehling Capital Management, Inc. Organon & Co. Transaction History
Poehling Capital Management, Inc.
- $391 Million
- Q1 2025
A detailed history of Poehling Capital Management, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Poehling Capital Management, Inc. holds 315,549 shares of OGN stock, worth $2.91 Million. This represents 1.2% of its overall portfolio holdings.
Number of Shares
315,549
Previous 324,804
2.85%
Holding current value
$2.91 Million
Previous $4.85 Million
3.05%
% of portfolio
1.2%
Previous 1.21%
Shares
16 transactions
Others Institutions Holding OGN
# of Institutions
809Shares Held
198MCall Options Held
1.84MPut Options Held
1.41M-
Black Rock Inc. New York, NY32.6MShares$300 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$274 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.7MShares$98.8 Million0.06% of portfolio
-
State Street Corp Boston, MA8.98MShares$82.8 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL7.98MShares$73.6 Million0.29% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $2.34B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...